ORCHESTRA Delphi Consensus: Clinical Management of SARS-CoV-2 Infection in People with HIV.

IF 10.9 1区 医学 Q1 INFECTIOUS DISEASES
Alessandro Tavelli, Alessandra Vergori, Antonella Cingolani, Francesca Bai, Anna Maria Azzini, Gabriel Levy Hara, Maria Giulia Caponcello, Matteo Rinaldi, Zaira R Palacios-Baena, Milo Gatti, Gaia Maccarrone, Evelina Tacconelli, Andrea Antinori, Antonella d'Arminio Monforte
{"title":"ORCHESTRA Delphi Consensus: Clinical Management of SARS-CoV-2 Infection in People with HIV.","authors":"Alessandro Tavelli, Alessandra Vergori, Antonella Cingolani, Francesca Bai, Anna Maria Azzini, Gabriel Levy Hara, Maria Giulia Caponcello, Matteo Rinaldi, Zaira R Palacios-Baena, Milo Gatti, Gaia Maccarrone, Evelina Tacconelli, Andrea Antinori, Antonella d'Arminio Monforte","doi":"10.1016/j.cmi.2025.03.006","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The interaction between HIV and COVID-19 resulted in a syndemic that showed an excess burden of disease for people with HIV (PWH). Four years of the COVID-19 pandemic have raised many unsolved questions about the optimal care of COVID in PWH.</p><p><strong>Methods: </strong>We performed a study using a 3-round Delphi methodology involving a panel of physicians with expertise in HIV and COVID-19 infections. The main aim of the study was to provide recommendations on critical clinical issues of COVID-19 among PWH and to inform physicians and policy-makers for improving care and prevention of COVID-19 in PWH. 27 questions were conceived, focusing on four main areas of interest in the management of COVID-19 in PWH; a panel of 34 experts in HIV and COVID-19 care expressed their level of agreement on each item. Questions that received agreement/disagreement ≥79.4% of panellists were identified and statements were generated accordingly.</p><p><strong>Results: </strong>Consensus was reached on 19/27 items, resulting in 18 final statements. These statements addressed: (I) risk of COVID-19 progression to severe disease among PWH; (II) COVID-19 diagnostics and laboratory procedures; (III) early treatments with antivirals and/or monoclonal antibodies; (IV) use of corticosteroids; (V) COVID-19 preventive strategies.</p><p><strong>Conclusions: </strong>This consensus's study guide infectious diseases physicians in making decisions regarding care of PWH for COVID-19, where results from the scientific literature are limited or conflicting.</p>","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology and Infection","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cmi.2025.03.006","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The interaction between HIV and COVID-19 resulted in a syndemic that showed an excess burden of disease for people with HIV (PWH). Four years of the COVID-19 pandemic have raised many unsolved questions about the optimal care of COVID in PWH.

Methods: We performed a study using a 3-round Delphi methodology involving a panel of physicians with expertise in HIV and COVID-19 infections. The main aim of the study was to provide recommendations on critical clinical issues of COVID-19 among PWH and to inform physicians and policy-makers for improving care and prevention of COVID-19 in PWH. 27 questions were conceived, focusing on four main areas of interest in the management of COVID-19 in PWH; a panel of 34 experts in HIV and COVID-19 care expressed their level of agreement on each item. Questions that received agreement/disagreement ≥79.4% of panellists were identified and statements were generated accordingly.

Results: Consensus was reached on 19/27 items, resulting in 18 final statements. These statements addressed: (I) risk of COVID-19 progression to severe disease among PWH; (II) COVID-19 diagnostics and laboratory procedures; (III) early treatments with antivirals and/or monoclonal antibodies; (IV) use of corticosteroids; (V) COVID-19 preventive strategies.

Conclusions: This consensus's study guide infectious diseases physicians in making decisions regarding care of PWH for COVID-19, where results from the scientific literature are limited or conflicting.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
25.30
自引率
2.10%
发文量
441
审稿时长
2-4 weeks
期刊介绍: Clinical Microbiology and Infection (CMI) is a monthly journal published by the European Society of Clinical Microbiology and Infectious Diseases. It focuses on peer-reviewed papers covering basic and applied research in microbiology, infectious diseases, virology, parasitology, immunology, and epidemiology as they relate to therapy and diagnostics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信